Synapse - Works

Results (22468)

Identification of actionable genomic alterations in hematologic malignancies by a clinical next generation sequencing-based assay

Meeting Abstract

Lipson, D.; Nahas, M. K.; Otto, G. A.; Yelensky, R.; Abdel-Wahab, O.; Wang, K.; He, J.; Intlekofer, A. M.; Rampal, R. K.; Brennan, T. A.; more...
Blood (2013)

Fulltext@MSK | Save

Patient derived xenograft (PDX) models faithfully recapitulate the genetic composition of primary AML

Meeting Abstract

Krivtsov, A. V.; Xujun, W.; Farnoud, N. R.; Hadler, M.; Knapp, K. M.; Stein, E. M.; Tallman, M. S.; Donahue, A. L.; Lipson, D.; Nahas, M. K.; more...
Blood (2013)

Fulltext@MSK | Save

JAK2 dependent GM-CSF signaling triggers SRSF2 phosphorylation: A potential cause of mutation-independent RNA splicing aberrancy in CMML

Meeting Abstract

Kunigal, S.; Teer, J.; Painter, J.; Yoder, S. J.; Kim, E.; Zhang, L.; Lancet, J. E.; Komrokji, R. S.; Abdel-Wahab, O.; List, A.; more...
Blood (2013)

Fulltext@MSK | Save

Chronic myeloid leukemia after adjuvant treatment for breast cancer: Is it therapy related?

Meeting Abstract

Kishtagari, A.; Bowman, I. A.; Tallman, M. S.; Douer, D.; Berman, E.; Maslak, P. G.; Brentjens, R. J.; Stein, E. M.
Blood (2013)

Fulltext@MSK | Save

Phase I trial of the targeted alpha-particle nano-generator actinium-225 ((225)Ac)-lintuzumab (anti-CD33) in combination with low-dose cytarabine (LDAC) for older patients with untreated acute myeloid leukemia (AML)

Meeting Abstract

Jurcic, J. G.; Ravandi, F.; Pagel, J. M.; Park, J. H.; Douer, D.; Estey, E. H.; Kantarjian, H. M.; Cicic, D.; Scheinberg, D. A.
Blood (2013)

Fulltext@MSK | Save

Two chemotherapy-based conditioning regimens compared to TBI-based conditioning secure consistent engraftment of T-cell depleted allogeneic HSCT, similarly low incidences of GVHD and favorable rates of disease-free survival (DFS)

Meeting Abstract

Koehne, G.; Boulad, F.; Klein, E. G.; Barker, J. N.; Castro-Malaspina, H. R.; Curran, K. J.; Giralt, S. A.; Goldberg, J. D.; Hasan, A. N.; Heller, G.; more...
Blood (2013)

Fulltext@MSK | Save

Higher than expected carrier frequency of the Dyskeratosis congenita RTEL1 p.Arg1264His recessive founder In individuals of Ashkenazi Jewish ancestry

Meeting Abstract

Jalas, C.; Fedick, A.; Ballew, B. J.; Alter, B. P.; Giri, N.; Boulton, S.; Offit, K.; Petrini, J.; Treff, N.; Savage, S. A.
Blood (2013)

Fulltext@MSK | Save

Profiling genomic alterations of diffuse large B-cell lymphoma (DLBCL) at diagnosis, relapse, and transformation, using a novel clinical diagnostic targeted sequencing platform

Meeting Abstract

Intlekofer, A. M.; Sheshan, V. E.; Levine, R. L.; Zelenetz, A. D.; Teruya-Feldstein, J.; Dogan, A.; Palomba, M. L.; Moskowitz, C. H.; van den Brink, M. R. M.; Knapp, K. M.; more...
Blood (2013)

Fulltext@MSK | Save

Generation and characterization of a third party GMP grade bank of CMV specific T-cells for adoptive immunotherapy of CMV infections in recipients of HSCT from cord blood or seronegative donors

Meeting Abstract

Hasan, A. N.; Doubrovina, E.; Koehne, G.; Prockop, S. E.; O'Reilly, R. J.
Blood (2013)

Fulltext@MSK | Save

Outcomes in patients with acute lymphoblastic leukemia in first or second complete remission receiving ex-vivo T-cell depleted or unmodified allografts: Comparison of results at two institutions

Meeting Abstract

Hobbs, G. S.; Hilden, P.; Hamdi, A.; Goldberg, J. D.; Poon, M.; Ledesma, C.; Devlin, S.; Rondon, G.; Papadopoulos, E. B.; Jakubowski, A. A.; more...
Blood (2013)

Fulltext@MSK | Save